Showing results (191-200 of 226) with videos related to
Sort By:
Pageof 23
Journal of Medical Genetics|October 30, 2007
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populationsM Witsch-Baumgartner, I Schwentner, M Gruber, et al.Circulation|January 19, 2005
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjectsS M Boekholdt, F M Sacks, J W Jukema, et al.Clinical Chemistry|November 22, 2014
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countriesMarta Futema, Sonia Shah, Jackie A Cooper, et al.Circulation. Cardiovascular Genetics|November 10, 2012
Integration of genetics into a systems model of electrocardiographic traits using HumanCVD BeadChipTom R Gaunt, Sonia Shah, Christopher P Nelson, et al.Annals of Human Genetics|May 4, 2011
Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChipDelilah Zabaneh, Tom R Gaunt, Meena Kumari, et al.Circulation|May 19, 2010
PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European AncestryJuan P Casas, Ewa Ninio, Andrie Panayiotou, et al.Atherosclerosis|September 1, 2014
A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart diseaseMichael V Holmes, Ruth Frikke-Schmidt, Daniela Melis, et al.Diabetes|December 6, 2014
Sixty-five common genetic variants and prediction of type 2 diabetesPhilippa J Talmud, Jackie A Cooper, Richard W Morris, et al.Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.Nature Communications|September 17, 2014
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in EuropeansNicholas J Timpson, Klaudia Walter, Josine L Min, et al.Pageof 23